Electrolyte purgative

Details Electrolyte purgative Electrolyte purgative

2011-08-09

2011-08-09

Richter, Johann (Department: 1616)

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Alkali metal or alkaline earth containing

C424S679000, C424S697000, C424S680000, C514S054000

Reexamination Certificate

active

07993682

ABSTRACT:
The invention relates to compositions for use in purgatives, to purgatives comprising such compositions, and to methods for inducing purgation of the colon. The composition may comprise at least one water-soluble sodium salt; at least one water-soluble minimally degradable sugar in an amount, by weight, of from about 1 to about 3 times the weight of sodium ions in said composition; at least one water-soluble potassium salt in an amount, by weight, of from about 0.05 to about 1 time the weight of said sodium salt in said composition; and at least one water-soluble magnesium salt, wherein the weight of magnesium ions in said composition is from 0.1 to about 10 times the weight of sodium ions in said composition.

REFERENCES:
patent: 4186025 (1980-01-01), Kang et al.
patent: 4452779 (1984-06-01), Cockerill
patent: 4766004 (1988-08-01), Moskowitz
patent: 4975286 (1990-12-01), Hechter
patent: 5173296 (1992-12-01), Andre et al.
patent: 5196205 (1993-03-01), Borody
patent: 5232699 (1993-08-01), Colliopoulos
patent: 5274001 (1993-12-01), Borody
patent: 5443826 (1995-08-01), Borody
patent: 5476669 (1995-12-01), Borody
patent: 5519014 (1996-05-01), Borody
patent: 5858403 (1999-01-01), Borody et al.
patent: 6103268 (2000-08-01), Borody et al.
patent: 6121250 (2000-09-01), Nishiyama et al.
patent: 6132767 (2000-10-01), Borody et al.
patent: 6162464 (2000-12-01), Jacob et al.
patent: 6277836 (2001-08-01), Borody
patent: 6426338 (2002-07-01), Borody
patent: 6475518 (2002-11-01), Baumgart
patent: 6489317 (2002-12-01), Borody
patent: 6551632 (2003-04-01), Borody
patent: 6645530 (2003-11-01), Borody
patent: 6774111 (2004-08-01), Wolf et al.
patent: 2002/0035075 (2002-03-01), Borody
patent: 2003/0180260 (2003-09-01), Clancy et al.
patent: 2004/0009961 (2004-01-01), Borody
patent: 2004/0028689 (2004-02-01), Borody
patent: 2004/0038329 (2004-02-01), Clancy et al.
patent: 2335713 (2001-01-01), None
patent: 0397689 (1990-11-01), None
patent: 0433299 (1991-06-01), None
patent: 0439453 (1991-08-01), None
patent: 0554291 (1993-08-01), None
patent: 0771562 (1997-05-01), None
patent: 05306221 (1993-11-01), None
patent: 2098100 (1997-12-01), None
patent: WO8501441 (1985-04-01), None
patent: WO8605981 (1986-10-01), None
patent: WO8903219 (1989-04-01), None
patent: WO8905659 (1989-06-01), None
patent: WO9001335 (1990-02-01), None
patent: WO9206690 (1992-04-01), None
patent: WO9602236 (1996-02-01), None
patent: WO9611014 (1996-04-01), None
patent: WO9843667 (1998-10-01), None
patent: WO9850043 (1998-11-01), None
patent: WO9956749 (1999-11-01), None
patent: WO0001378 (2000-01-01), None
patent: WO 01/67895 (2001-09-01), None
patent: WO0180852 (2001-11-01), None
patent: WO0197821 (2001-12-01), None
patent: WO0203065 (2002-01-01), None
patent: WO0207741 (2002-01-01), None
patent: WO03061767 (2003-07-01), None
patent: WO2004070043 (2004-08-01), None
Schiller, L.R., Review article: The Therapy of Constipation, 2001, Alimentary Pharmacology and Theraputics, vol. 15, pp. 749-763.
JP 07242539 A, Fukahori et al., Compositions having laxative effect, used in treatment of constipation comprise organic acid, sugar alcohol, and optional calcium salts, 1995, Derwent Abstract, pp. 1-7.
Dye, D., “The inadequacy of the usual determinative tests for the identification of Xanthomonas SPP,” New Zealand Journal of Science 5(4):393-416 (1962).
Altomare DF, Memeo V, “Colonic explosion during diathermy colotomy. Report of a case”,Diseases Colon Rectum Mar;36(3):291-2 (1993).
Andrews PJ, Borody TJ, “‘Putting back the bugs’: bacterial treatment relieves chronic constipation and symptoms of irritable bowel syndrome ”,Med J Aust. Nov. 1;159(9):633-4 (1993).
Arieff AI, Llach F, Massry SG, “Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes”,Medicine(Baltimore)Mar;55(2):121-9 (1976).
Borody TJ, “‘Flora Power’—fecal bacteria cure chronic C. difficile diarrhea”,Am J Gastroenterol. Nov;95(I I):3028-9 (2000).
Borody TJ, “Helicobacter pylori eradication failure—‘salvage’ therapies needed”,Ital J Gastroenterol Hepatol. Aug;30(4):375-7 (1998).
Borody TJ, Andrews P, Jankiewicz E, Ferch N, Carroll M, “Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori”,Am J Gastroenterol. Aug;88(8):1266-68 (1993).
Borody TJ, Ashman O., “Lactoferrin: milking ulcers?”,Dig Liver Dis. Oct.;35(10):691-3. (2003).
Borody TJ, Brandl S, Andrews P, Ferch N, Jankiewicz E, Hyland L, “Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori”,Am J Gastroenterol. Jan;89(1):33-8 (1994).
Borody TJ, George L, Andrews P, Brandl S, Noonan S, Cole P, Hyland L, Morgan A, Maysey J, Moore-Jones D, “Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome?”,Med J Aust. May 15;150(10):604 (1989).
Borody TJ, George LL, Brandt S, Andrews P, Lenne J, Moore-Jones D, Devine M, Walton M, “Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy”,Scand J Gastroenterol. Apr.;27(4):281-4 (1992).
Borody TJ, Shortis NP, Reyes E, “Eradication therapies for Helicobacter pylori”,J Gastroenterol. 33 Suppl10:53-6 (1998).
Borody TJ, Warren EF, Leis S, Surace R, Ashman O, “Treatment of ulcerative colitis using fecal bacteriotherapy”,J Clin Gastroenterol. Jul;37(1):42-7 (2003).
Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas S., “Bacteriotherapy using fecal flora: toying with human motions”,J Clin Gastroenterol Jul;38(6):475-83 (2004).
Cohen CD, Keuneke C, Schiemann U, Schroppel B, Siegert S, Rascher W, Gross M, Schlondorff D, “Hyponatraemia as a complication of colonoscopy”,Lancet Jan 27;357(9252):282-3 (2001).
de Boer WA, Borody TJ, “Treatment failures and secondary resistance to antibiotics. A growing concern in Helicobacter pylori therapy”,Dig Liver Dis. Nov;32(8):673-5 (2000).
Derwent Abstract Accession No. 93-408836, Class B05, JP 05306221 A (Horii Yakunhin Kogyo KK) Nov. 19, 1993 Abstract Only.
Derwent Abstract Accession No. 98-375395, Class B05, RU 2098100 C1 (Maksimova et al.) Dec. 10, 1997 Abstract Only.
Fincher RK, Osgard EM, Jackson JL, Strong JS, Wong RK, “A comparison of bowel preparations for flexible sigmoidoscopy: oral magnesium citrate combined with oral bisacodyl, one hypertonic phosphate enema, or two hypertonic phosphate enemas”,Am J Gastroenterol Aug.;94(8):2122-7 (1999).
Fraser CL, Kucharczyk J, Arieff AI, Rollin C, Sarnacki P, Norman D, “Sex differences result in increased morbidity from hyponatremia in female rats”,Am J Physiol. Apr;256(4 Pt 2):R880-5 (1989).
Melton JE, Patlak CS, Pettigrew KD, Cserr HF “Volume regulatory loss of Na, C1, and K from rat brain during acute hyponatremia”,Am J Physiol.Apr;252(4 Pt 2):F661-9 (1987).
Certified English language translation of Japanese Patent Document No. JP 05306221, Kawakami, Y., “Intestinal canal irrigation solution composition and intestinal canal irrigation solution,” Nov. 19, 1993.

Affiliated with

Also associated with

Rating

Electrolyte purgative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Electrolyte purgative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Electrolyte purgative will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2761163